retatrutide developer eli lilly leads in obesity treatment and CMC innovation Lilly shares safety, tolerability data

[1] Although numerous anti-epileptic drugs (AEDs) are available, nearly one-third of patients continue to experience drug-resistant seizures, emphasizing the urgent need to explore alternative mechanisms beyond conventional genetic and ion-channel theories

The phenomenon known as "Ozempic mouth" characterised by dry mouth and bad breath has contributed to a 20 percentage point uplift in mouthwash spending among GLP-1 user households compared with non-users

During the fifth voting round, a final questionnaire with updated grading for the seven recommendations was disseminated to the group, and 100% consensus was achieved with 16 out of 16 questionnaires returned (Box 1)

It should also be noted that, from a methodological perspective, the model used (Cox with stratification by cardiovascular risk class of the trials, i.e., SURPASS-4: high risk, and all others: low risk) requires various assumptions, including the homogeneity of the relative effect of tirzepatide treatment on MACE regardless of the baseline cardiovascular risk level of the patients

The scale delivers better news than you have seen in years